Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 20-11-2013 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline Sale of Aspen Pharmacare Stake | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May advised GlaxoSmithKline plc on the sale of approximately one-third of its 19 per cent. stake in Aspen Pharmacare Holdings Ltd which was announced on 20 November 2013. Aspen is listed on the Johannesburg Stock Exchange. The disposal was effected by way of an accelerated bookbuilt offering and raised net proceeds of approximately GBP425 million at the prevailing exchange rate on 19 November 2013. Following settlement of the sale, GSK will hold approximately 12.4% of the issued share capital of Aspen.
UBS Limited and Citigroup Global Markets Limited acted as Joint Bookrunners on the offering.
Corporate and Commercial: David Johnson (partner), Richard Smith (partner), Gemma Carr (associate), Emma Plaxton (associate).
|
||
| Financial Center: | London | Value: | 500.01-1000.00 |
| Advised Party: | Vendor | Law Firm | Slaughter and May |
| Target Company Jurisdiction: | Latvia | Acquiror Jurisdiction: | United Kingdom |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | David Johnson |
